Literature DB >> 1345846

Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia.

U B Wandl, O Kloke, N Niederle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1345846     DOI： 10.1016/0140-6736(92)91030-c

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Development of granulomatous hepatitis during treatment with interferon-alpha 2b.

Authors:  A Propst; T Propst; O Dietze; H Kathrein; G Judmeier; W Vogel
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

Review 2.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

Review 3.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

4.  The optimum inhibitory effects of Alpha Interferon and Cisplatin in colon cancer, a comparative in vitro study.

Authors:  Arafat Muttar; Ihab Ahmed; Huda Hameed
Journal:  J Med Life       Date:  2022-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.